<?xml version="1.0" encoding="UTF-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /Users/melina/Documents/js/scrape/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<encodingDesc>
			<appInfo>
				<application version="0.5.1-SNAPSHOT" ident="GROBID" when="2018-02-21T06:50+0000">
					<ref target="https://github.com/kermitt2/grobid">GROBID - A machine learning software for extracting information from scholarly documents</ref>
				</application>
			</appInfo>
		</encodingDesc>
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">A Comparison of Dynamic Reposing and Tangent Distance for Drug Activity Prediction</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thomas</forename><forename type="middle">G</forename><surname>Dietterich</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">Arris Pharmaceutical Corporation and MIT Artificial Intelligence Laboratory 545 Technology Square Cambridge</orgName>
								<orgName type="institution" key="instit1">Arris Pharmaceutical Corporation</orgName>
								<orgName type="institution" key="instit2">Oregon State University Corvallis</orgName>
								<orgName type="institution" key="instit3">Arris Pharmaceutical Corporation</orgName>
								<address>
									<addrLine>385 Oyster Point Blvd., Suite 3 South San Francisco</addrLine>
									<postCode>97331-3202, 94080, 02139</postCode>
									<region>OR, CA, MA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ajay</forename><forename type="middle">N</forename><surname>Jain</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">Arris Pharmaceutical Corporation and MIT Artificial Intelligence Laboratory 545 Technology Square Cambridge</orgName>
								<orgName type="institution" key="instit1">Arris Pharmaceutical Corporation</orgName>
								<orgName type="institution" key="instit2">Oregon State University Corvallis</orgName>
								<orgName type="institution" key="instit3">Arris Pharmaceutical Corporation</orgName>
								<address>
									<addrLine>385 Oyster Point Blvd., Suite 3 South San Francisco</addrLine>
									<postCode>97331-3202, 94080, 02139</postCode>
									<region>OR, CA, MA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">H</forename><surname>Lathrop</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">Arris Pharmaceutical Corporation and MIT Artificial Intelligence Laboratory 545 Technology Square Cambridge</orgName>
								<orgName type="institution" key="instit1">Arris Pharmaceutical Corporation</orgName>
								<orgName type="institution" key="instit2">Oregon State University Corvallis</orgName>
								<orgName type="institution" key="instit3">Arris Pharmaceutical Corporation</orgName>
								<address>
									<addrLine>385 Oyster Point Blvd., Suite 3 South San Francisco</addrLine>
									<postCode>97331-3202, 94080, 02139</postCode>
									<region>OR, CA, MA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomas</forename><surname>Lozano-Perez</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">Arris Pharmaceutical Corporation and MIT Artificial Intelligence Laboratory 545 Technology Square Cambridge</orgName>
								<orgName type="institution" key="instit1">Arris Pharmaceutical Corporation</orgName>
								<orgName type="institution" key="instit2">Oregon State University Corvallis</orgName>
								<orgName type="institution" key="instit3">Arris Pharmaceutical Corporation</orgName>
								<address>
									<addrLine>385 Oyster Point Blvd., Suite 3 South San Francisco</addrLine>
									<postCode>97331-3202, 94080, 02139</postCode>
									<region>OR, CA, MA</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">A Comparison of Dynamic Reposing and Tangent Distance for Drug Activity Prediction</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<profileDesc>
			<abstract>
				<p>In drug activity prediction (as in handwritten character recognition), the features extracted to describe a training example depend on the pose (location, orientation, etc.) of the example. In handwritten character recognition, one of the best techniques for addressing this problem is the tangent distance method of Simard, LeCun and Denker (1993). Jain, et al. (1993a; 1993b) introduce a new technique-dynamic reposing-that also addresses this problem. Dynamic reposing iteratively learns a neural network and then reposes the examples in an effort to maximize the predicted output values. New models are trained and new poses computed until models and poses converge. This paper compares dynamic reposing to the tangent distance method on the task of predicting the biological activity of musk compounds. In a 20-fold cross-validation, 216 A Comparison of Dynamic Reposing and Tangent Distance for Drug Activity Prediction 217 dynamic reposing attains 91 % correct compared to 79% for the tangent distance method, 75% for a neural network with standard poses, and 75% for the nearest neighbor method.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
	</text>
</TEI>
